May 20th 2025
HHS announces plan to create ‘most-favored-nation’ cost scale so U.S. is not subsidizing drug prices in other countries.
May 19th 2025
A new study in JAMA Health Forum finds women primary care physicians earn more under value-based models — while delivering better outcomes and fewer hospital visits.
May 16th 2025
House Budget Committee takes up debate and AMGA publishes projections due to Medicaid cuts in One Big Beautiful Bill Act.
May 15th 2025
Trump administration tallies ‘staggering cost’ of opioid epidemic as lawmakers ponder budget.
Congressional committees review spending with Health and Human Services Department leader.
Introducing AIMPA: State regulation of medicine
A new advocacy organization for independent physicians.
Introducing AIMPA: Starting a new national group
Introducing AIMPA: Primary care physicians are welcome
Medicare drug price negotiations could hurt patients by disincentivizing research
PhRMA, U.S. Chamber warn of unintended consequences, market effects of negotiations.
CMS kicks off price negotiations with Big Pharma for 10 drugs for Medicare
Administration, HHS tout milestone day on road to lowering drug prices for beneficiaries.
Introducing AIMPA: Getting attention of policymakers
Introducing AIMPA: Quality, access, cost
Introducing AIMPA: Laser-focused on independents
Introducing AIMPA: Benefits of independent practice
Introducing AIMPA: Meet the group of independents
Pharma CEO: Let's have transparency in prescription drug pricing
It's time for pharmaceutical companies and others to innovate and disrupt the distribution side of treatment.
The independent medical practice is not dead
AIMPA intends to become a new voice for physicians in independent practice.
Medicare leaders target PBMs, insurance coverage, pharmacy competition
Prescription drug prices, vaccine costs are also key issues.
Prescription drug rebates are coming: CMS
In 2024, beneficiaries could see savings per dose, according to new guidance on price increases relative to inflation.
AIMPA to Congress: Don’t cut Medicare reimbursements
Independent doctors group says cuts would result in higher costs and less access to care for patients
President targets high prescription drug prices with ‘march-in’ authority
Public-private partnerships will crumble, hurting drug innovation and eventually patients, Republicans say.
‘Independent medical practices are not dead’
AIMPA intends to become a new voice for independent physicians across all specialties, including primary care.
New national group aims to be voice for independent physicians
AIMPA launches this week to advocate for specialists contending ‘consolidation has not led to better care or lower costs for patients.’
Is too much regulation stifling health care innovation?
Why has innovation in health care not kept pace with other sectors of the economy? Harman Dhawan, founder and CEO of Bikham Healthcare, offers his take and some possible solutions.
Reducing physician burnout starts with increasing advocacy
Advocacy takes time-a rarity for physicians. But there are five simple ways to advocate for needed healthcare changes.